ETA

ENERGY TRANSITION ACCELERATOR AND WORLD BANK ANNOUNCE STRATEGIC COLLABORATION TO SCALE UP CLEAN ENERGY FINANCE

Retrieved on: 
Tuesday, September 19, 2023
Climate Policy Initiative, Private sector, Partnership, Rockefeller Foundation, EDF, U.S. Department of Defense Strategy for Operating in Cyberspace, CPI, International Energy Agency, Policy, Sustainable Development Goal 7, United States Department of Energy, World Bank Group, Jeff Bezos, Environmental Defense Fund, Multimedia, World Bank, Carbon, GFANZ, Energy transition, Organization, ETA, United States Department of State, SCALE, Developed country, Investment, Sustainable Development Goals, Climate Week NYC, Winrock International, Climate, Glasgow, Sustainable development, News, EnergySolutions, Cryptocurrency, Renewable energy

NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The U.S. Department of State, the Bezos Earth Fund, The Rockefeller Foundation, and the World Bank today announced a strategic collaboration between the Energy Transition Accelerator (ETA) and the World Bank to mobilize finance to support just, accelerated energy transitions in developing countries.

Key Points: 
  • NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The U.S. Department of State, the Bezos Earth Fund, The Rockefeller Foundation, and the World Bank today announced a strategic collaboration between the Energy Transition Accelerator (ETA) and the World Bank to mobilize finance to support just, accelerated energy transitions in developing countries.
  • The strategic collaboration between ETA and SCALE, announced at a Climate Week event hosted by The Rockefeller Foundation, aims to leverage the strengths of each initiative to mobilize finance for effective energy transitions.
  • The United States, the first contributor to SCALE, will work with the World Bank to enlist other contributors.
  • "The Energy Transition Accelerator and the World Bank's SCALE initiative each bring vital tools to this effort.

New Majority Capital Expands bETA Accelerator Nationally

Retrieved on: 
Monday, September 18, 2023
Entrepreneurship, Small business, Partnership, US Census Bureau International Data Base, JPMorgan Chase, The Icehouse (business growth centre), Black, NMC, ETA, United States Census Bureau, Financial Health Network, Retirement, Acquisition, Beta, City, BIPOC, Empowerment, Pharmaceutical industry, Management

BOSTON, Sept. 18, 2023 /PRNewswire/ -- New Majority Capital (NMC) today announced the expansion of bETA, a 10-week accelerator designed to increase BIPOC adoption of Entrepreneurship through Acquisition (ETA), through several new cohorts across the United States.

Key Points: 
  • BOSTON, Sept. 18, 2023 /PRNewswire/ -- New Majority Capital (NMC) today announced the expansion of bETA, a 10-week accelerator designed to increase BIPOC adoption of Entrepreneurship through Acquisition (ETA), through several new cohorts across the United States.
  • The goals of the bETA accelerator are to demystify the ETA process, make participants capital-ready, and ultimately aid participants in their acquisition of a small business.
  • "We are thrilled to take this important mission around the country," says Allegra Stennett, Co-Founder of New Majority Capital.
  • "Advancing Black Pathways connects Black entrepreneurs with resources such as the bETA accelerator in partnership with New Majority Capital to support their business pursuits," said Eva Brown, Head of Business Growth & Entrepreneurship and Financial Health and Wealth, Advancing Black Pathways.

Lassen Therapeutics Presents New Data on LASN01 for the Treatment of Idiopathic Pulmonary Fibrosis and Thyroid Eye Disease at the European Respiratory Society (ERS) and European Thyroid Association (ETA) Annual Meetings

Retrieved on: 
Monday, September 11, 2023
Science, Biotechnology, Research, Pharmaceutical, Optical, Oncology, Health, Clinical Trials, Well, STAT3, Therapy, Phosphorylation, Half-life, HA, Cancer, Cell proliferation, MBA, Doctor of Philosophy, ERS, Graves' ophthalmopathy, ETA, Teprotumumab, Patient, European Respiratory Society, Extracellular matrix, IPF, International Congress on Tuberculosis, Idiopathic pulmonary fibrosis, VI, TED, Pharmaceutical industry, Vaccine, Lassen

“Toward that, we have made significant progress in generating data with LASN01 in both clinical and nonclinical settings.

Key Points: 
  • “Toward that, we have made significant progress in generating data with LASN01 in both clinical and nonclinical settings.
  • We have completed our Phase 1 single ascending and multiple ascending dose cohorts and presented data from our healthy volunteer study at ERS.
  • We also presented our preclinical data in a TED fibro-inflammatory disease model using orbital fibroblasts (OF) at ETA.
  • Furthermore, LASN01 worked effectively in combination with teprotumumab, an approved agent for the treatment of TED, in inhibiting HA release.

Viridian Therapeutics Announces Presentations at Multiple Medical Meetings in September

Retrieved on: 
Thursday, September 7, 2023
Health, General Health, Research, Science, Pharmaceutical, Optical, Biotechnology, Abstract, American Thyroid Association, ATA, Graves' ophthalmopathy, DC, ETA, Annual general meeting, European Society of Clinical Microbiology and Infectious Diseases, Pharmacology, Therapy, TED, Pharmaceutical industry, Vaccine, Patient

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that multiple abstracts featuring clinical and preclinical data on the Company’s pipeline candidates for the treatment of thyroid eye disease (TED) will be presented at the following medical meetings:

Key Points: 
  • Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that multiple abstracts featuring clinical and preclinical data on the Company’s pipeline candidates for the treatment of thyroid eye disease (TED) will be presented at the following medical meetings:
    The 45th Annual Meeting of the European Thyroid Association (ETA) to be held September 9-12, 2023, in Milan, Italy
    The 41st Annual Meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS) to be held September 14-16, 2023, in Naples, Italy
    The Annual Meeting of the American Thyroid Association (ATA) to be held September 27-October 1, 2023, in Washington, DC
    Presentations at all three conferences will highlight clinical and pharmacologic data from studies of VRDN-001, a full antagonist antibody to the insulin-like growth factor-1 receptor (IGF-1R), in development for TED.
  • An additional presentation will feature pharmacokinetic data for VRDN-003, a next-generation, half-life extended antibody to IGF-1R for TED.
  • The Company will also present clinical pharmacodynamic responses to VRDN-001 in healthy volunteers and patients with active TED.
  • VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor: In Vitro Pharmacology and Phase 1/2 Results in Patients with Thyroid Eye Disease
    Preclinical Pharmacokinetics and Clinical Exposure Prediction for VRDN-003, a Next-Generation Half-life Extended Antibody to IGF-1R for Thyroid Eye Disease
    In Vitro Pharmacology and Phase 1/2 Results of VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease

Bettermile Revolutionizes US Parcel Delivery with AI-Powered Logistics Software-as-a-Service Platform

Retrieved on: 
Thursday, September 7, 2023
Software, Artificial Intelligence, Trucking, Technology, Logistics, Supply Chain Management, Transport, Retail, Delivery Services, ETA, Communication, Transportation management system, Live, TMS, Food delivery, Online shopping, Cargo

Bettermile , a global, AI-powered parcel delivery logistics platform currently available in 13 countries, has expanded its North American availability to include the United States, aiming to transform the crucial last mile of delivery for the country's parcel and courier service providers.

Key Points: 
  • Bettermile , a global, AI-powered parcel delivery logistics platform currently available in 13 countries, has expanded its North American availability to include the United States, aiming to transform the crucial last mile of delivery for the country's parcel and courier service providers.
  • In an era dominated by ambiguous “next-day” shipping and e-commerce-forward purchasing, the still heavily-analog parcel delivery industry grapples with unparalleled challenges.
  • Armed with groundbreaking solutions designed to revolutionize the last-mile delivery, Bettermile empowers parcel and courier companies with essential tools to excel in this ever-evolving terrain.
  • Bettermile's commitment to operational efficiency, location intelligence, and future-proofing delivery operations paves the way for unparalleled success in the highly competitive parcel delivery landscape.

EROAD Product Enhancements Enable Improvements in Driver Safety, Operational Transformation, and Tax and Compliance

Retrieved on: 
Wednesday, September 6, 2023
ETA, Drag Race Eliminator, Internet of things, SAN, Feature, Safety, Online shopping, Mobile phone

SAN DIEGO, Sept. 6, 2023 /PRNewswire/ -- EROAD, a global leader in fleet performance management, today announced a number of product enhancements designed to help fleet customers improve driver safety, streamline operations, and bolster supply chain visibility. Updates have been made to EROAD's Clarity Dashcam, refrigerated trailer door sensor, and route planner, and new fuel card integrations introduced for easier tax reporting and fuel use analysis.

Key Points: 
  • Updates have been made to EROAD's Clarity Dashcam, refrigerated trailer door sensor, and route planner, and new fuel card integrations introduced for easier tax reporting and fuel use analysis.
  • "Our Summer 2023 product updates span a variety of operational functions critically important to today's fleet operators."
  • EROAD Clarity Dashcam enhancements – Reduce manual work and further streamline reviews to improve drivers' safety, provide greater visibility into coaching opportunities, and easily identify high-risk driving behaviors.
  • For more information about EROAD's summer 2023 product enhancements, visit https://www.eroad.com/ .

Yamaha Selects project44 Ocean Visibility Solution to enhance Supply Chain Resiliency

Retrieved on: 
Wednesday, September 6, 2023
Yamaha Corporation, ETA, Transport, GM, Nursing, Retail, Yamaha

TOKYO, Sept. 6, 2023 /PRNewswire/ -- project44, the leading supply chain visibility platform, today announced that Yamaha Corporation ("Yamaha") is now deploying project44's Ocean Visibility and Port Intel solutions. As the world's largest musical instrument manufacturer and a maker of quality audio equipment, Yamaha selected project44 to improve visibility of its global shipments, enhance its supply chain resilience and optimize its supply chain.

Key Points: 
  • TOKYO, Sept. 6, 2023 /PRNewswire/ -- project44, the leading supply chain visibility platform, today announced that Yamaha Corporation ("Yamaha") is now deploying project44's Ocean Visibility and Port Intel solutions.
  • As the world's largest musical instrument manufacturer and a maker of quality audio equipment, Yamaha selected project44 to improve visibility of its global shipments, enhance its supply chain resilience and optimize its supply chain.
  • As part of a supply chain resiliency initiative at Yamaha, they evaluated solutions to improve the control of transportation between production factories and distributors.
  • We believe that project44 will help Yamaha  for collaborative planning and exception management, resulting in more satisfied Yamaha customers."

HPC International Releases Three New Editions of Their Best-selling Book Series Hope & Destiny for Patients with Sickle Cell Disease

Retrieved on: 
Wednesday, September 6, 2023
Destiny, Partnership, DATE, Education, Health, Parent, SCD, The Oregon Trail 3rd Edition, Doctor of Philosophy, ETA, Hospital, Publishing, Hope, Patient, HPC, Hematology, Pain management, Sickle cell disease, FACS, Health communication, Book, MMSc, Caregiver, Disease, Pharmaceutical industry, Nursing, MD

Chicago, Illinois, Sept. 06, 2023 (GLOBE NEWSWIRE) -- HPC International , a leading purchased services supplier for healthcare, corporations and academic institutions, has announced the release of three new editions of their best-selling book series, Hope & Destiny, written specifically for patients with sickle cell disease (SCD), an inherited disorder of the red blood cells that disproportionately affects people of color.

Key Points: 
  • Chicago, Illinois, Sept. 06, 2023 (GLOBE NEWSWIRE) -- HPC International , a leading purchased services supplier for healthcare, corporations and academic institutions, has announced the release of three new editions of their best-selling book series, Hope & Destiny, written specifically for patients with sickle cell disease (SCD), an inherited disorder of the red blood cells that disproportionately affects people of color.
  • “HPC International’s vast majority of in-house published books and educational resources are sold to healthcare organizations, which can distribute them directly to patients for free,” said HPC International CEO Hilton M. Hudson, MD, FACS.
  • The educational content in the Pinpoint™ app comes from the renowned and best-selling Hope & Destiny book series.
  • For more information or to purchase the Hope & Destiny book series, visit HPC International .

Wego and VisitBritain announce boost in bookings to Britain through its 'Spilling the tea on GREAT Britain' partnership campaign

Retrieved on: 
Tuesday, September 5, 2023
Tea, Partnership, Travel, VisitBritain, GCC, Social media, Visa, Electronic visa, Government, 2014 UK government review of the Muslim Brotherhood, ETA, Beauty, City, Growth, MENA, UK, Drug, Tourism, Wego

DUBAI, UAE, Sept. 5, 2023 /PRNewswire/ -- A partnership between Wego, the largest online travel marketplace in the Middle East and North Africa (MENA), and VisitBritain, Britain's national tourism agency, has seen a 25% boost in bookings to Great Britain.

Key Points: 
  • The multi-media advertising partnership campaign "Spilling the Tea on Great Britain," which ran between January to June 2023, used a play on Britain's love of tea, inviting visitors to "See Things Differently."
  • The campaign promoted Britain's rich cultural heritage, breathtaking coastlines and landscapes, as well as its dynamic cities and destinations including London, Newcastle, Edinburgh and Manchester.
  • Additionally, passenger numbers traveling to Great Britain through Wego are up 27% during the same timeframe.
  • Wego VP of Brand Marketing and Social Media, Roxana Nicolescu, said: "We are absolutely delighted with the campaign growth figures that our partnership with VisitBritain has achieved.

Wego and VisitBritain announce boost in bookings to Britain through its 'Spilling the tea on GREAT Britain' partnership campaign

Retrieved on: 
Tuesday, September 5, 2023
Tea, Partnership, Travel, VisitBritain, GCC, Social media, Visa, Electronic visa, Government, 2014 UK government review of the Muslim Brotherhood, ETA, Beauty, City, Growth, MENA, UK, Drug, Tourism, Wego

DUBAI, UAE, Sept. 5, 2023 /PRNewswire/ -- A partnership between Wego, the largest online travel marketplace in the Middle East and North Africa (MENA), and VisitBritain, Britain's national tourism agency, has seen a 25% boost in bookings to Great Britain.

Key Points: 
  • The multi-media advertising partnership campaign "Spilling the Tea on Great Britain," which ran between January to June 2023, used a play on Britain's love of tea, inviting visitors to "See Things Differently."
  • The campaign promoted Britain's rich cultural heritage, breathtaking coastlines and landscapes, as well as its dynamic cities and destinations including London, Newcastle, Edinburgh and Manchester.
  • Additionally, passenger numbers traveling to Great Britain through Wego are up 27% during the same timeframe.
  • Wego VP of Brand Marketing and Social Media, Roxana Nicolescu, said: "We are absolutely delighted with the campaign growth figures that our partnership with VisitBritain has achieved.